CONCORD HC GP (02453): Successfully Develops Autonomous Multi-Modal Intelligent Agent Architecture, Intelligent Health Examination Report System Begins Trial

Stock News
Yesterday

CONCORD HC GP (02453) announced that the company has achieved significant progress in artificial intelligence. Based on its proprietary optimized large language model, the company has successfully developed an autonomous multi-modal intelligent agent architecture and created a revolutionary intelligent health examination report system, which has begun trial use at partner institutions.

The system employs a top-tier expert thinking chain model that continuously learns and updates cutting-edge medical knowledge in real-time. It comprehensively analyzes users' multi-modal data including medical imaging, laboratory tests, and medical history to generate personalized health reports. By eliminating human bias and precisely identifying complex health risks, the system significantly reduces misdiagnosis and missed diagnosis rates.

The system supports real-time connectivity across remote medical nodes and generates expert-level reports within seconds, ensuring that grassroots medical institutions have access to tertiary hospital-level analytical capabilities, making quality medical resources universally accessible.

The transition from traditional to intelligent health examinations represents not merely a technological improvement, but an industry transformation. This system transforms every piece of health examination data into an intelligent guide for precision health management.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10